Analysis of differential PDT effect in rat bladder tumor models according to concentrations of intravesical hexyl-aminolevulinate
- PMID: 18754047
- DOI: 10.1039/b804921a
Analysis of differential PDT effect in rat bladder tumor models according to concentrations of intravesical hexyl-aminolevulinate
Abstract
The hexylester of 5-aminolevulinic acid (HAL) is a very efficient precursor of the photosensitizer protoporphyrin IX (PpIX) for photodynamic therapy (PDT). Our previous study, performed in rat orthotopic bladder tumors, indicated an opposite effect of HAL/PpIX-PDT according to HAL concentration. The present study investigated possible reasons for this differential effect considering the impact of extracted amounts of PpIX in normal and tumor bearing bladders along with PpIX distribution in distinctive histopathological layers. High performance liquid chromatography (HPLC) analysis of tumor and normal bladder tissues after 8 mM and 16 mM HAL instillation showed that PpIX was the main porphyrin species. The PpIX production in tumor bladders instilled with 8 mM HAL was significantly higher than after 16 mM HAL. Fluorescence confocal microscopy demonstrated a punctuate bright fluorescence pattern in tumor zones of bladders instilled with 8 mM HAL, whereas a more diffuse cytoplasmatic fluorescence distribution was observed after 16 mM HAL instillation. Immunofluorescence staining together with transmission electron microscopy showed severe mitochondrial damage in tumor zones of bladders treated with 8 mM HAL/PpIX PDT, with intact mitochondria in tumor zones of bladders treated with 16 mM HAL/PpIX PDT. We conclude that the differential response to HAL/PpIX PDT in function of HAL concentrations could be attributed to diminished PpIX synthesis and differential intracellular localisation of PpIX. Mitochondria were shown to be the critical photodamaged sites of HAL/PpIX PDT and as such tissue sensitivity to treatment can be estimated through investigation of intracellular PpIX distribution.
Similar articles
-
Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.J Urol. 2003 Aug;170(2 Pt 1):428-32. doi: 10.1097/01.ju.0000075054.38441.2d. J Urol. 2003. PMID: 12853792 Clinical Trial.
-
Biodistribution of PVP-hypericin and hexaminolevulinate-induced PpIX in normal and orthotopic tumor-bearing rat urinary bladder.Cancer Chemother Pharmacol. 2011 Apr;67(4):775-81. doi: 10.1007/s00280-010-1375-0. Epub 2010 Jun 9. Cancer Chemother Pharmacol. 2011. PMID: 20532886
-
Kinetics, biodistribution and therapeutic efficacy of hexylester 5-aminolevulinate induced photodynamic therapy in an orthotopic rat bladder tumor model.J Urol. 2004 Nov;172(5 Pt 1):2013-7. doi: 10.1097/01.ju.0000135816.46544.74. J Urol. 2004. PMID: 15540780
-
Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for Enhancement.Int J Mol Sci. 2015 Oct 28;16(10):25865-80. doi: 10.3390/ijms161025865. Int J Mol Sci. 2015. PMID: 26516850 Free PMC article. Review.
-
Photodynamic Therapy for Bladder Cancers, A Focused Review†.Photochem Photobiol. 2023 Mar;99(2):420-436. doi: 10.1111/php.13726. Epub 2022 Oct 14. Photochem Photobiol. 2023. PMID: 36138552 Free PMC article. Review.
Cited by
-
Prodrug strategies for targeted therapy triggered by reactive oxygen species.Medchemcomm. 2019 May 8;10(9):1531-1549. doi: 10.1039/c9md00169g. eCollection 2019 Sep 1. Medchemcomm. 2019. PMID: 31673314 Free PMC article. Review.
-
Enlarging the Scope of 5-Aminolevulinic Acid-Mediated Photodiagnosis towards Breast Cancers.Int J Mol Sci. 2022 Nov 28;23(23):14900. doi: 10.3390/ijms232314900. Int J Mol Sci. 2022. PMID: 36499224 Free PMC article.
-
Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities.Pharmaceuticals (Basel). 2010 May 14;3(5):1507-1529. doi: 10.3390/ph3051507. Pharmaceuticals (Basel). 2010. PMID: 27713315 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical